DENVER--(BUSINESS WIRE)--KRG Capital Partners (“KRG”) today announced that Daniel E. Greenleaf will become President and Chief Executive Officer of Home Solutions, one of the nation’s leading specialty infusion companies, effective immediately.
Mr. Greenleaf, who most recently served as President and Chief Executive Officer for Coram Specialty Infusion Services as well as Chief Operating Officer for Apria Healthcare, will, as President and Chief Executive Officer of Home Solutions, be responsible for leading the rapidly-growing home infusion portfolio company of KRG.
“We are extremely pleased to bring Dan on as the President and CEO of Home Solutions,” said Steve Neumann, Managing Director of KRG. “There is no better leader in the home infusion industry than Dan. His strong executive skills and commercial and operations background bring the crucial elements to achieve significant growth, operational efficiencies, and continued success for Home Solutions.”
Mr. Greenleaf joined as President of Coram in April 2008 and led Coram to become the industry leader in home infusion and one of the top-performing healthcare companies in the U.S. with a double-digit compounded annual growth rate and an EBITDA increase of more than 250%. Coram recently agreed to be acquired by CVS Caremark for $2.1 billion after having been purchased by Apria Healthcare in late 2007 for $350 million, attesting to the value created through Mr. Greenleaf’s nearly five years at the helm. In addition to his role as President and CEO of Coram, Mr. Greenleaf also served as Chief Operating Officer for Apria Healthcare’s respiratory therapy/home medical equipment business from November 2010 to March 2012. In this role he reorganized and revitalized the company with significant progress made on the business priorities and objectives, including improvements made in sales performance, revenue management, ancillary services, patient census, and customer service. Since his departure from Coram, Mr. Greenleaf has provided expertise through consulting and advisory services to several blue chip private equity firms in healthcare services.
Mr. Greenleaf has over 21 years of relevant experience in senior leadership positions in the healthcare industry. Prior to joining Coram and Apria, Mr. Greenleaf served as President and CEO for VioQuest Pharmaceuticals Inc., a publically traded biopharmaceutical company. Additionally, he was the President of U.S. Operations for Celltech Biopharmaceuticals, which sold for $2.7 billion. Mr. Greenleaf was also held senior leadership roles with Nabi Pharmaceuticals and Schering-Plough Corporation.
Mr. Greenleaf serves on the University of Miami’s Health Sector Management and Policy Board, and is a past board member for the National Home Infusion Association (NHIA). He has also been a member of the international group, Young President’s Organization (YPO), since 2004.
A graduate of Denison University with a Bachelor of Arts (B.A.) in Economics, Mr. Greenleaf also holds a Master of Business Administration (M.B.A.) in Health Administration from the University of Miami. A military veteran, Mr. Greenleaf was a captain and navigator in the United States Air Force and served in Operation Desert Storm.
About Home Solutions
Home Solutions, headquartered in Hammonton, New Jersey, is a leading specialty infusion provider servicing approximately 14,000 patients annually throughout the Northeastern and Mid-Atlantic regions of the U.S. The Company is committed to clinical excellence, compassion and professionalism. Home Solutions is Joint Commission accredited and provides a full range of infusion and specialty services in the home and alternate setting. Our commitment is to put the patient first in delivering a quality service while offering cost effective solutions to various industry stakeholders such as physicians, hospitals, managed care payors, and governmental agencies. InfuLink®, the Company’s proprietary web monitoring tool, shares data with healthcare providers to help optimize clinical outcomes.
More information about Home Solutions is available at www.infusioncare.com.
About KRG Capital Partners
Founded in 1996, KRG is a Denver based private equity buyout firm with $4.4 billion of cumulative capital either deployed or available for future investment, which includes approximately $1.1 billion deployed since inception by institutional equity co-investors. The Firm seeks investment opportunities for its partners where KRG can work in concert with owners and operating managers who are committed to expanding their companies and becoming industry leaders. The result is a partnership that focuses on creating a significantly larger enterprise through a combination of internal growth and complementary add-on acquisitions. Since inception, KRG has invested in 45 platform companies and has completed 141 add-on acquisitions for those platforms.
More information about KRG is available at www.krgcapital.com.